Editas Medicine vs Sarepta
Editas Medicine vs Sarepta, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Editas Medicine is on 42/100 and Sarepta on 21/100.
Where each one leads
Editas Medicine
- our overall score: 42/100 against 21/100
- agent readiness: 39/100 against 34/100
Sarepta
- domain rating: 68/100 against 61/100
- headcount: 1,162 against 185
- LinkedIn following: 138,724 against 52,616
At a glance
| Measure | Editas Medicine | Sarepta |
|---|---|---|
| What it is | A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases. | Biopharmaceutical company focused on developing RNA-targeted therapies for rare genetic diseases. |
| Category | Biotech, MedTech, Genomics, Drug Discovery | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2013 | Not published |
| Headquarters | Cambridge, United States | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Editas Medicine | Sarepta |
|---|---|---|
| Employees | 185 | 1,162 |
| Open roles | Not published | 19 |
| Total funding | $210M | Not published |
| Latest round | Series B | Not published |
| LinkedIn followers | 52,616 | 138,724 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Editas Medicine | Sarepta |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 42/100 | 21/100 |
| Traction | 60/100 | 20/100 |
| Search visibility | 27/100 | 25/100 |
| Quality | 45/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (34/100) |
| Domain ratingLink authority, 0-100 | 61/100 | 68/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Editas Medicine | Sarepta |
|---|---|---|
| Hosting | Not detected | AWS |
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Jquery |
| Analytics | Google Tag Manager | Not detected |
What users say
| Measure | Editas Medicine | Sarepta |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 1 positive, 0 negative across 1 thread |
“Sarepta Therapeutics is a commercial-stage biopharmaceutical company that focuses on the discovery and development of RNA-targeted therapeutics, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. $SRP”r/
Editas Medicine vs Sarepta: common questions
Which is better, Editas Medicine or Sarepta?
On our 0-100 score Editas Medicine rates higher (42/100 against 21/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Editas Medicine and Sarepta compare on the numbers?
Editas Medicine leads on our overall score (42/100 against 21/100), agent readiness (39/100 against 34/100). Sarepta leads on domain rating (68/100 against 61/100), headcount (1,162 against 185), LinkedIn following (138,724 against 52,616).
What do real users say about Editas Medicine and Sarepta?
Sarepta: 1 positive and 0 negative mentions across 1 Reddit threads we track.
Read the full Editas Medicine review and pricing or the Sarepta review and pricing. You can also browse other Editas Medicine alternatives we track.